Universe Pharmaceuticals INC (UPC)

NASDAQ: UPC · IEX Real-Time Price · USD
2.190
+0.290 (15.26%)
At close: Mar 28, 2024, 4:00 PM
2.250
+0.060 (2.74%)
After-hours: Mar 28, 2024, 6:45 PM EDT
15.26%
Market Cap 7.98M
Revenue (ttm) 32.31M
Net Income (ttm) -6.16M
Shares Out 3.65M
EPS (ttm) -1.70
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 146,501
Open 1.990
Previous Close 1.900
Day's Range 1.990 - 2.330
52-Week Range 0.750 - 5.880
Beta 1.74
Analysts n/a
Price Target n/a
Earnings Date Apr 9, 2024

About UPC

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceut... [Read more]

Sector Healthcare
IPO Date Mar 23, 2021
Employees 225
Stock Exchange NASDAQ
Ticker Symbol UPC
Full Company Profile

Financial Performance

In 2023, UPC's revenue was $32.31 million, a decrease of -19.52% compared to the previous year's $40.14 million. Losses were -$6.16 million, -29.46% less than in 2022.

Financial Statements

News

Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results

JI'AN, China, Jan. 30, 2024 /PRNewswire/ -- Universe Pharmaceuticals INC ("Universe Pharmaceuticals" or the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announce...

2 months ago - PRNewsWire

Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares

Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today an...

8 months ago - GlobeNewsWire

Universe Pharmaceuticals INC Announces Share Consolidation

Jiangxi, China, July 27, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today an...

8 months ago - GlobeNewsWire

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022

JI'AN, China, Aug. 16, 2022 /PRNewswire/ -- Universe Pharmaceuticals INC (the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial resu...

1 year ago - PRNewsWire

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Ji'an, Jiangxi, China, July 19, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Compan...

1 year ago - GlobeNewsWire

Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms

Ji'an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Compa...

2 years ago - GlobeNewsWire

Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine

Ji'an, Jiangxi, China, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Compan...

2 years ago - GlobeNewsWire

Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer

Ji'an, Jiangxi, China, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Compan...

2 years ago - GlobeNewsWire

Universe Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese Medicine

Ji'an, Jiangxi, China, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on Decembe...

2 years ago - GlobeNewsWire

Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021

Ji'an, Jiangxi, China, July 30, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that it will re...

2 years ago - GlobeNewsWire

Universe Pharmaceuticals INC Announces Full Exercise of Underwriter's Over-Allotment Option in the Public Offering

Ji'an, Jiangxi, China, March 31, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the underwrite...

3 years ago - GlobeNewsWire

Universe Pharmaceuticals INC Announces Closing of Initial Public Offering

Ji'an, Jiangxi, China, March 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the closing of...

3 years ago - GlobeNewsWire

Universe Pharmaceuticals INC Announces Pricing and Trading of Initial Public Offering

Ji'an, Jiangxi, China, March 23, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”), a pharmaceutical producer and distributor in China, today announced the pricing of its initial p...

3 years ago - GlobeNewsWire